Biology of human TH1 and TH2 cells
- PMID: 7559914
- DOI: 10.1007/BF01543103
Biology of human TH1 and TH2 cells
Abstract
Evidence is accumulating to suggest the existence of polarized human T-cell responses, reminiscent of TH1 and TH2 subsets described for mouse T cells. Human TH1 cells preferentially develop during infections by intracellular bacteria and trigger phagocyte-mediated host defense, whereas TH2 cells, which predominate during helminthic infestations and in response to common environmental allergens, are responsible for phagocyte-independent host response. Human TH1 and TH2 cells exhibit not only different functional properties but probably also distinct surface markers; TH2, but not TH1, clones express membrane CD30 and release the soluble form of CD30, a member of the TNF receptor superfamily. The cytokine profile of "natural immunity" evoked by different offending agents in the context of different host genetic backgrounds appears to be the most critical factor in determining the phenotype of the subsequent specific response. IL-12 and IFN-alpha and gamma produced by macrophages and NK cells favor the development of TH1 cells, whereas the early production of IL-4 by a still-unidentified cell type favors the development of TH2 cells. Clearly, polarized human TH1 and TH2 responses not only play different roles in protection, they can also promote different immunopathological reactions. Strong and persistent TH1 responses seen to be involved in organ-specific autoimmunity, contact dermatitis, and some chronic inflammatory disorders of unknown etiology. In contrast, polarized TH2 responses favor a reduced protection against the majority of infectious agents (including HIV) and, in genetically predisposed hosts, are responsible for triggering of allergic atopic disorders.
Similar articles
-
Role for CD30 antigen in human T helper 2-type responses.Ciba Found Symp. 1995;195:55-62; discussion 62-7. doi: 10.1002/9780470514849.ch5. Ciba Found Symp. 1995. PMID: 8724830 Review.
-
Th1/Th2 cells.Inflamm Bowel Dis. 1999 Nov;5(4):285-94. doi: 10.1097/00054725-199911000-00009. Inflamm Bowel Dis. 1999. PMID: 10579123 Review.
-
Lymphokine production by human T cells in disease states.Annu Rev Immunol. 1994;12:227-57. doi: 10.1146/annurev.iy.12.040194.001303. Annu Rev Immunol. 1994. PMID: 8011282 Review.
-
Th1 and Th2 in human diseases.Clin Immunol Immunopathol. 1996 Sep;80(3 Pt 1):225-35. doi: 10.1006/clin.1996.0118. Clin Immunol Immunopathol. 1996. PMID: 8811042 Review.
-
An update on human Th1 and Th2 cells.Int Arch Allergy Immunol. 1997 May-Jul;113(1-3):153-6. doi: 10.1159/000237532. Int Arch Allergy Immunol. 1997. PMID: 9130508 Review.
Cited by
-
New Insights into HIV Life Cycle, Th1/Th2 Shift during HIV Infection and Preferential Virus Infection of Th2 Cells: Implications of Early HIV Treatment Initiation and Care.Life (Basel). 2024 Jan 9;14(1):104. doi: 10.3390/life14010104. Life (Basel). 2024. PMID: 38255719 Free PMC article. Review.
-
The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals.Cancer Discov. 2022 Apr 1;12(4):958-983. doi: 10.1158/2159-8290.CD-21-1441. Cancer Discov. 2022. PMID: 35179201 Free PMC article.
-
Saliva and Serum Cytokine Profiles During Oral Ulceration in Behçet's Disease.Front Immunol. 2021 Dec 22;12:724900. doi: 10.3389/fimmu.2021.724900. eCollection 2021. Front Immunol. 2021. PMID: 35003055 Free PMC article.
-
The HLA-G Immune Checkpoint Plays a Pivotal Role in the Regulation of Immune Response in Autoimmune Diseases.Int J Mol Sci. 2021 Dec 12;22(24):13348. doi: 10.3390/ijms222413348. Int J Mol Sci. 2021. PMID: 34948145 Free PMC article. Review.
-
Epigallocatechin-3-Gallate as a Novel Vaccine Adjuvant.Front Immunol. 2021 Nov 12;12:769088. doi: 10.3389/fimmu.2021.769088. eCollection 2021. Front Immunol. 2021. PMID: 34868027 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources